摘要:隨著我國經濟的迅猛發展，中小企業在國民經濟增長中占著不可或缺的重要地位，其數量占全國企業總數的99%以上，提供了80%的城鎮就業崗位，同時創造了60%的國內生產總值和50%的稅收。然而，中小企業由于規模較小、科技水平不高等因素的限制，融資問題已經成為制約很多中小企業持續發展的主要問題之一。而制藥行業是一個高投入高風險高回報的行業，是關乎國計民生的重要產業部門。因此，研究制藥企業的融資模式問題具有一定的現實意義。

　　　本文綜述了國內外學者對融資的研究成果，概述了融資的基本理論，論述了南通精華制藥股份有限公司的融資現狀以及影響公司融資模式的因素，分析了該公司不同融資模式下的盈利質量，提出了完善南通精華制藥股份有限公司融資模式的建議。

關鍵詞 南通精華制藥股份有限公司；中小企業；融資模式

Abstract:With the rapid development of China's economic, small and medium enterprises ( SMEs) occupied an important position in the national economic growth. The number of  SMEs in China has reached 99% of the total number of enterprises. SMEs have provided 80% of urban jobs and created 60% of GDP and 50% of the taxes. However, due to the objective constraints of smaller scale and  lower level of science and technology ,the financing of  SMEs has become one of the outstanding problems constraining the healthy development of SMEs.The pharmaceutical industry is a industry of high investment ,high risk and high return .It is an important industry sectors related to people's livelihood. Therefore, the research on the financing model of pharmaceutical companies has a certain practical significance.

   This thesis reviewed the research of domestic and foreign scholars on the financing, discussed the present situation of financing status of Jinghua Pharmaceutical Co., Ltd. as well as factors that affected the company's financing, analyzed the company's earnings quality of different financing modes ,and put forward to the countermeasures to financing mode .

Keywords  NanTong Jinghua Pharmaceutical Co.,Ltd.  small and medium enterprises   financing model